Intuitive Surgical (NASDAQ:ISRG) Given New $655.00 Price Target at Bernstein Bank

Intuitive Surgical (NASDAQ:ISRG) had its price objective lifted by Bernstein Bank from $650.00 to $655.00 in a report released on Monday. Bernstein Bank’s price objective suggests a potential upside of 13.99% from the stock’s previous close.

Several other equities analysts have also recently commented on ISRG. BTIG Research increased their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Citigroup increased their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday. Truist Financial increased their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research report on Friday. Finally, Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $610.95.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded down $9.46 during trading on Monday, reaching $574.59. 1,391,095 shares of the company’s stock were exchanged, compared to its average volume of 1,954,819. The company’s 50-day moving average is $547.16 and its two-hundred day moving average is $505.21. Intuitive Surgical has a 52-week low of $364.17 and a 52-week high of $616.00. The firm has a market cap of $204.66 billion, a price-to-earnings ratio of 92.27, a PEG ratio of 5.19 and a beta of 1.39.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 42,453 shares of company stock worth $22,059,506 in the last quarter. 0.90% of the stock is currently owned by corporate insiders.

Institutional Trading of Intuitive Surgical

Several institutional investors have recently made changes to their positions in the business. AQR Capital Management LLC raised its stake in shares of Intuitive Surgical by 12.6% during the second quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock worth $18,958,000 after buying an additional 4,775 shares during the last quarter. Creative Planning lifted its position in Intuitive Surgical by 9.8% during the second quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock worth $28,043,000 after acquiring an additional 5,629 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of Intuitive Surgical by 8.2% in the second quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock valued at $6,150,000 after buying an additional 1,044 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its stake in Intuitive Surgical by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock valued at $9,100,000 after acquiring an additional 411 shares during the last quarter. Finally, Wellington Wealth Strategies LLC. bought a new stake in shares of Intuitive Surgical during the second quarter worth $241,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.